| Term 
 | Definition 
 
        | -Narcotic analgesic -CNS depressant
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -CNS Depression - binds to opiate receptors in the brain -Decreases pain perception and anxiety
 -Relaxes respiratory effort
 -Produces peripheral vasodialation; thereby decreasing blood return to the heart (preload)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Chest pain of suspected cardiac origin - pain, anxiety relief; if nitro ineffective -Moderate to severe pain (burns or isolated extremity trauma)
 -Abdominal pain (non-traumatic, suspected kidney stones
 -Discomfort secondary to transcutaneous pacing in the awake patient
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2-20mg in 2mg increments slow IVP; titrated to pain relief and respiratory response |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Respiratory depression and/or arrest -Decreased LOC
 -Transient hypotension
 -Nausea/vomiting (stimulation of vomiting center)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Known hypersensitivity to the drug -Volume depletion
 -Suspected ectopic pregnancy, abruptio placenta or abdominal aortic aneurysm
 -Unstable vital signs
 -Head injury
 -MAO inhibitors within 14 days
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Narcan will reverse overdose effects -Monitor B/P, pulse, and respiratory rates between increments
 -Utilize caution with patients with COPD, asthma, compromised respirations and the elderly
 -Consider utilization of narcan if pt demonstrates respiratory arrest or hypotension post administration (narcan may not reverse hypotension)
 -Assess effectiveness of administration with assessment of pain and respiratory status of patient
 -Anticipate vomiting
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Refer to pediatric drug guide -0.1-0.1mg/kg slow IVP to a max of 5mg (usual range)
 |  | 
        |  |